scholarly article | Q13442814 |
P50 | author | Fabrice Soncin | Q37373925 |
Hervé Chneiweiss | Q43119133 | ||
Pascale Varlet | Q56923825 | ||
Eva Maria Galan-Moya | Q59659373 | ||
Julie Gavard | Q60299826 | ||
P2093 | author name string | Marie-Pierre Junier | |
Bertrand Devaux | |||
Cédric Broussard | |||
Philippe Chafey | |||
Luiz Gustavo Dubois | |||
Sébastien Pinte | |||
Cécile Thirant | |||
P2860 | cites work | Temporal analysis of neural differentiation using quantitative proteomics | Q24648790 |
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response | Q27860541 | ||
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
A new method for predicting signal sequence cleavage sites | Q27861117 | ||
A truncated form of p23 down-regulates telomerase activity via disruption of Hsp90 function | Q28115203 | ||
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma | Q28236409 | ||
Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor | Q28241567 | ||
Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration | Q28291731 | ||
Expression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activity | Q28593381 | ||
A perivascular niche for brain tumor stem cells | Q29614276 | ||
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors | Q29615393 | ||
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines | Q29615823 | ||
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor | Q29617062 | ||
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Q29619677 | ||
Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors. | Q30997872 | ||
Identification of differentiating neural progenitor cell markers using shotgun isobaric tagging mass spectrometry | Q33250413 | ||
Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domain | Q33304584 | ||
Comparative proteomic analysis of proteins involved in cell aggregation during neural differentiation of P19 mouse embryonic carcinoma cells | Q33416586 | ||
CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors | Q33534016 | ||
What role(s) for TGFalpha in the central nervous system? | Q33951992 | ||
Potential therapeutic implications of cancer stem cells in glioblastoma | Q33965491 | ||
NAD+ and vitamin B3: from metabolism to therapies | Q34009126 | ||
NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. | Q34085883 | ||
Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer | Q34106493 | ||
Vascular endothelial growth factor increases neurogenesis after traumatic brain injury | Q34171058 | ||
Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | Q34215219 | ||
The terminal prostaglandin synthases mPGES-1, mPGES-2, and cPGES are all overexpressed in human gliomas | Q34974329 | ||
Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy | Q35023906 | ||
Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation. | Q35631417 | ||
HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity | Q35757997 | ||
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma | Q36103026 | ||
Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. | Q36132447 | ||
Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination | Q36445546 | ||
Angiogenesis in brain tumours | Q36887534 | ||
Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis | Q37133686 | ||
Signaling in adult neurogenesis. | Q37540178 | ||
Fatty acid binding proteins in brain development and disease | Q37766513 | ||
Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting | Q37825821 | ||
CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target | Q37826381 | ||
Signal transduction inhibitors and antiangiogenic therapies for malignant glioma | Q37847104 | ||
Large-scale identification of proteins expressed in mouse embryonic stem cells. | Q38520867 | ||
EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction | Q39462780 | ||
The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network | Q39514879 | ||
CHIP Promotes Human Telomerase Reverse Transcriptase Degradation and Negatively Regulates Telomerase Activity | Q39642191 | ||
Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas | Q39692289 | ||
Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: towards the identification of putative biomarkers | Q39768653 | ||
Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells | Q39777292 | ||
DLG1/SAP97 modulates transforming growth factor alpha bioavailability | Q39928049 | ||
Blood-brain barrier-specific properties of a human adult brain endothelial cell line | Q40377619 | ||
Expression of hepatoma‐derived growth factor in hepatocellular carcinoma | Q40631524 | ||
Neural stem/progenitor cells promote endothelial cell morphogenesis and protect endothelial cells against ischemia via HIF-1alpha-regulated VEGF signaling | Q42159303 | ||
Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway. | Q42728935 | ||
Partial purification and characterization of human hepatoma-derived growth factor | Q42796084 | ||
Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor | Q42833272 | ||
Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas | Q44007768 | ||
Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation | Q44065642 | ||
Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders. | Q45230647 | ||
Alternative lengthening of telomeres in human glioma stem cells. | Q45373303 | ||
The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. | Q46016867 | ||
Long-term expansion of adult human brain subventricular zone precursors | Q46732941 | ||
An essential role for Rac1 in endothelial cell function and vascular development. | Q46775495 | ||
Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma | Q46902291 | ||
Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells | Q48180382 | ||
Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase-1. | Q48912859 | ||
Genes associated with fast glioma cell migration in vitro and in vivo | Q48960334 | ||
Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. | Q51547758 | ||
Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer. | Q51779050 | ||
Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. | Q51799739 | ||
Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF). | Q52062332 | ||
Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors. | Q53554653 | ||
Proteomic analysis of neural differentiation of mouse embryonic stem cells. | Q53653750 | ||
Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. | Q54523318 | ||
The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. | Q55463049 | ||
SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. | Q55465654 | ||
New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases. | Q55471697 | ||
P433 | issue | 5 | |
P921 | main subject | glioblastoma | Q282142 |
neural stem cell | Q2944097 | ||
P304 | page(s) | 845-853 | |
P577 | publication date | 2012-05-01 | |
P1433 | published in | Stem Cells | Q15724411 |
P1476 | title | Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor | |
P478 | volume | 30 |
Q37697462 | A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma |
Q35368468 | A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression |
Q38222157 | Cancer secretomes and their place in supplementing other hallmarks of cancer |
Q52610219 | Cell-Specific PEAR1 Methylation Studies Reveal a Locus that Coordinates Expression of Multiple Genes. |
Q90136485 | Cellular Interactions in the Tumor Microenvironment: The Role of Secretome |
Q47964508 | Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness. |
Q38235552 | Concise reviews: cancer stem cells: from concept to cure. |
Q38066416 | Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies. |
Q40736209 | Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy. |
Q35135190 | Endothelial secreted factors suppress mitogen deprivation-induced autophagy and apoptosis in glioblastoma stem-like cells |
Q55379488 | Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells. |
Q92444223 | Extracellular Vesicle-Mediated Communication between the Glioblastoma and Its Microenvironment |
Q52149372 | Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma. |
Q28079663 | Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy |
Q26765758 | Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets |
Q26765854 | Glioma Stem Cells: Signaling, Microenvironment, and Therapy |
Q38252480 | HDGF: a novel jack-of-all-trades in cancer |
Q35170009 | HIV-1 IN/Pol recruits LEDGF/p75 into viral particles |
Q38816238 | Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells |
Q38859147 | Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension. |
Q42736263 | Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2. |
Q38952715 | Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma |
Q33776557 | How stem cells speak with host immune cells in inflammatory brain diseases |
Q36663387 | Hypoxia enhances stemness of cancer stem cells in glioblastoma: an in vitro study |
Q99616791 | Molecular subtyping of glioblastoma based on immune-related genes for prognosis |
Q93104522 | Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue |
Q48422165 | Proteome and Secretome Characterization of Glioblastoma-Derived Neural Stem Cells |
Q34992525 | Quantitative proteomics identifies host factors modulated during acute hepatitis E virus infection in the swine model |
Q27311252 | Radiation therapy-induced tumor invasiveness is associated with SDF-1-regulated macrophage mobilization and vasculogenesis |
Q39333626 | Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation |
Q47753685 | Sirtuin-2 activity is required for glioma stem cell proliferation arrest but not necrosis induced by resveratrol |
Q26862078 | The Oct4 protein: more than a magic stemness marker |
Q43794017 | The Prescient Prognosticator? Hepatoma-derived Growth Factor in Pulmonary Hypertension |
Q34046737 | The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathway |
Q43246559 | The expression and clinical significance of HDGF in osteosarcoma |
Q50903271 | The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome. |
Q35154977 | The secretome of endothelial progenitor cells promotes brain endothelial cell activity through PI3-kinase and MAP-kinase |
Q37590893 | Transcriptional and Genomic Targets of Neural Stem Cells for Functional Recovery after Hemorrhagic Stroke. |
Q42183898 | β-escin selectively targets the glioblastoma-initiating cell population and reduces cell viability. |
Search more.